An update on photodynamic therapy in age-related macular degeneration
- 1 July 2002
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 3 (7) , 931-938
- https://doi.org/10.1517/14656566.3.7.931
Abstract
Age-related macular degeneration (AMD) is the leading cause of irreversible loss of central vision in people aged > 50 years in the western world. Until recently, the only proven treatment to reduce the risk of vision loss from its more severe neovascular form was laser photocoagulation, but this treatment was suitable for only 15% of cases. Photodynamic therapy (PDT) with verteporfin was recently proposed to be effective in reducing the risk of visual loss for an estimated 20 - 30% of neovascular AMD patients. This review covers AMD epidemiology, the mechanism of PDT, the 2-year results of the two major clinical studies of PDT with verteporfin, the cost-effectiveness of PDT and the current research status of other drugs for PDT in AMD.Keywords
This publication has 12 references indexed in Scilit:
- GUIDELINES FOR USING VERTEPORFIN (VISUDYNE®) IN PHOTODYNAMIC THERAPY TO TREAT CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSESRetina, 2002
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Risk factors for age-related macular degenerationOphthalmology, 2001
- Mechanisms of Action of Photodynamic Therapy with Verteporfin for the Treatment of Age-Related Macular DegenerationSurvey of Ophthalmology, 2000
- Extracts from "Clinical Evidence": Age related macular degenerationBMJ, 2000
- Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degenerationOphthalmology, 1999
- Risk Factors for Choroidal Neovascularization in the Second Eye of Patients With Juxtafoveal or Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1997
- The Prevalence of Age-related Maculopathy in the Rotterdam StudyPublished by Elsevier ,1995
- The Impact of the Macular Photocoagulation Study Results on the Treatment of Exudative Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1995
- Five-Year Follow-up of Fellow Eyes of Patients With Age-Related Macular Degeneration and Unilateral Extrafoveal Choroidal NeovascularizationArchives of Ophthalmology (1950), 1993